KJKatarina Jovanovic

Katarina Jovanovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katarina Jovanovic has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Bianca Da Costa Dias

    Centre for HIV and Sexually Transmitted Infections, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa

    2 shared publications
  • Stefan F. T. Weiss

    School of Molecular and Cell Biology University of the Witwatersrand Johannesburg South Africa

    2 shared publications
  • Aadilah Omar

    Department of Internal Medicine Oncology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    1 shared publication
  • Bertram Brenig

    Institute of Veterinary Medicine, University of Göttingen, Göttingen, Germany

    1 shared publication
  • Chantal Zuber

    Laboratorium für Molekulare Biologie, Genzentrum, Institut für Biochemie der LMU, München, Feodor-Lynen-Strasse 25, D-81377 München, Germany

    1 shared publication
  • Danielle Gonsalves

    School of Molecular and Cell Biology; University of the Witwatersrand; Private Bag 3, Wits 2050, Johannesburg, Republic of South Africa (RSA)

    1 shared publication

Latest Publications

  • Open Access

    Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids

    by Dimitra Athanasiou, Tess A. V. Afanasyeva, Niuzheng Chai, Kalliopi Ziaka, Katarina Jovanovic, Rosellina Guarascio, Karsten Boldt, Julio C. Corral-Serrano, Naheed Kanuga, Ronald Roepman, et al.

    Bialleleic pathogenic variants in LCA5 cause one of the most severe forms of Leber congenital amaurosis, an early-onset retinal disease that results in severe visual impairment. Here, we report the use of gene editing to generate isogenic LCA5 knock-out (LCA5 KO) induced pluripotent stem cells (iPSC) and their differentiation to retinal organoids. The molecular and cellular phenotype of the LCA5 KO retinal organoids was studied in detail and compared to isogenic controls as well as patient-derived retinal organoids. The absence of LCA5 was confirmed in retinal organoids by immunohistochemistry and western blotting. There were no major changes in retinal organoid differentiation or ciliation, however, the localisation of CEP290 and IFT88 was significantly altered in LCA5 KO and patient photoreceptor cilia with extension along the axoneme. The LCA5-deficient organoids also had shorter outer segments and rhodopsin was mislocalised to the outer nuclear layer. We also identified transcriptomic and proteomic changes associated with the loss of LCA5. Importantly, treatment with the small molecules eupatilin, fasudil or a combination of both drugs reduced CEP290 and IFT88 accumulation along the cilia. The treatments also improved rhodopsin traffic to the outer segment and reduced mislocalisation of rhodopsin in the outer nuclear layer (ONL). The improvements in cilia-associated protein localisation and traffic were accompanied by significant changes in the transcriptome towards control gene expression levels in many of the differentially expressed genes. In summary, iPSC-derived retinal organoids are a powerful model for investigating the molecular and cellular changes associated with loss of LCA5 function and highlight the therapeutic potential of small molecules to treat retinal ciliopathies.


  • Open Access

    Structural and mechanistic commonalities of amyloid-β and the prion protein

    by Bianca Da Costa Dias, Katarina Jovanovic, Danielle Gonsalves, Stefan F.T. Weiss

    Amyloid β (Aβ) is a major causative agent of Alzheime disease. This neurotoxic peptide is generated as a result of the cleavage of the Amyloid-Precursor-Protein (APP) by the action of beta secretase and gamma secretase. The neurotoxicity was previously thought to be the result of aggregation. However, recent studies suggest that the interaction of Aβ with numerous cell surface receptors such as N-methyl-D-aspartate (NMDA), receptor for advanced glycosylation end products (RAGE), P75 neurotrophin receptor (P75NTR) as well as cell surface proteins such as the cellular prion protein (PrPc) and heparan sulfate proteoglycans (HSPG) strongly enhances Aβ induced apoptosis and thereby contributes to neurotoxicity. This review focuses on the molecular mechanism resulting in Aβ-shedding as well as Aβ-induced apoptotic processes, genetic risk factors for familial Alzheimer disease and interactions of Aβ with cell surface receptors and proteins, with particular emphasis on the cellular prion protein. Furthermore, comparisons are drawn between Alzheimer disease and prion disorders and the role of laminin, an extracellular matrix protein, glycosaminoglycans and the 37 kDa/67 kDa laminin receptor (LRP/LR) have been highlighted with regards to both neurodegenerative diseases.


  • Prion Interaction with the 37-kDa/67-kDa Laminin Receptor on Enterocytes as a Cellular Model for Intestinal Uptake of Prions

    by Dominika Kolodziejczak, Bianca Da Costa Dias, Chantal Zuber, Katarina Jovanovic, Aadilah Omar, Julia Beck, Karen Vana, Vusi Mbazima, Juergen Richt, Bertram Brenig, et al.